title: The subcutaneous ICD-current evidence and challenges.
abstract: The subcutaneous implantable cardioverter-defibrillator (S-ICD) represents an exciting development in ICD technology. It has relative advantages over traditional transvenous systems, particularly for young patients in whom the lifetime risk of device-related complications may be deemed to be unacceptably high. While data relating to device longevity and long term safety profile is yet to be accrued, several recent studies have demonstrated good clinical efficacy comparable to transvenous ICDs. Indeed, new techniques have also been developed to simplify the S-ICD implantation procedure and attempts have been made to address challenges pertaining to T-wave oversensing to reduce the delivery of inappropriate shocks. The impact of inappropriate shocks and lack of anti-tachycardia pacing (ATP) function are not only contentious matters, but also have important implications for patients in whom the S-ICD would be suitable. It is envisaged that subsequent models of this device will be less cumbersome, with the possibility that an entirely leadless pacemaker-defibrillator will one day be possible. Although the S-ICD may not completely replace transvenous devices in its current form, evidence suggests that it is a viable alternative particularly in preventing sudden cardiac death in non-pacing dependent patients.
authors.affiliation: Department of Cardiology, The Heart Hospital, University College London, London W1G 8PH, UK.
authors.forename: Kiran Haresh Kumar
authors.initials: KH
authors.lastname: Patel
authors.affiliation: Department of Cardiology, The Heart Hospital, University College London, London W1G 8PH, UK.
authors.forename: Pier D
authors.initials: PD
authors.lastname: Lambiase
keywords: Subcutaneous implantable cardioverter-defibrillator (S-ICD); sudden cardiac death